JUAN LAWRENCE CABATU: Open Payments
NPI 1093184582 · WESTCHESTER, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$28,386 in 85 payments from 7 companies in 2025. Trend: 2023 $15,650 · 2024 $22,230 · 2025 $28,386
Speaker / faculty: $18,788Travel & lodging: $3,520Honoraria: $3,500Food & beverage: $2,318Consulting: $155Education: $104
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 39 | $12,821 |
| Teva Pharmaceuticals USA, Inc. | 24 | $10,452 |
| Axsome Therapeutics, Inc. | 6 | $4,702 |
| E.R. Squibb & Sons, L.L.C. | 8 | $226 |
| Alpha Cognition USA, Inc. | 5 | $132 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: NUPLAZID, AUSTEDO XR, COBENFY, Zunveyl, INGREZZA, REXULTI, AJOVY.
Industry payments across IL — which companies pay providers there.
